Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

One pill to stop breast pain after pregnancy loss: new trial underway

NCT ID NCT07492160

First seen Apr 06, 2026 · Last updated May 01, 2026 · Updated 3 times

Summary

This study tests whether a single dose of cabergoline can prevent breast symptoms like pain, swelling, and milk leakage after abortion or pregnancy loss between 12 and 18 weeks. About 348 participants will receive either cabergoline or a placebo one hour after the procedure and report their symptoms over two weeks. The goal is to find a safe, effective way to ease this common discomfort.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maimonides Medical Center

    RECRUITING

    Brooklyn, New York, 11219, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.